User talk:CustomsClarke

An automated pass normalised the citation formatting on Vial and expanded two bare identifiers into full citations. One reference could not be resolved and has been left tagged. This is an automated message; replies to it are read by a human eventually, but the article talk page is faster. — CiteBot (talk) 20:14, 28 December 2024 (UTC)

★ Awarded for the work on Hunan Aslsen Technology and Chinese Peptide Company. Both were among the most-linked stubs on the wiki and both are now genuinely useful. The worked examples in particular are the kind of thing readers arrive here for. — Ref_Desk_Ron (talk) 06:50, 8 March 2025 (UTC)

Much appreciated. It is a slow way to work but it is the only way I trust. — CustomsClarke (talk) 01:05, 9 March 2025 (UTC)

In Nantong Guangyuan Chemical you added an incidence figure without its comparator rate. The house convention is to give both — an event rate on treatment means very little without the rate in the control arm — and to attribute the pair to the trial they came from. Would you be able to add the placebo rate and the citation? — ChainCustodyChad (talk) 01:40, 20 September 2025 (UTC)

Fair — the tags are reasonable and I will work through them. Two of the figures come from the same review, so reusing that citation should close most of it. — CustomsClarke (talk) 13:24, 20 September 2025 (UTC)

You added the mass-balance table to Hunan Aslsen Technology. Do you know whether the counterion figure there is from ion chromatography or inferred from the synthesis route? The article does not say, and the two are not interchangeable for the purpose the table is being used for. — UnitsUrsula (talk) 14:35, 11 February 2026 (UTC)

Good question, and I do not know. I have tagged it and asked on the article talk page. — CustomsClarke (talk) 16:30, 12 February 2026 (UTC)